Regeneron COVID Antibody Treatment Gets Emergency Use Authorization from the FDA

the staff of the Ridgewood blog Ridgewood NJ, according to Johns Hopkins Center for Health Security , the US FDA issued an Emergency Use Authorization (EUA) for another monoclonal antibody treatment for COVID-19. The newest EUA is for a combination therapy using casirivimab and imdevimab, developed by Regeneron Pharmaceuticals, which are monoclonal antibodies that target the receptor binding … Continue reading Regeneron COVID Antibody Treatment Gets Emergency Use Authorization from the FDA